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Abstract
Replacement of canonical histones with specialized histone vari-
ants promotes altering of chromatin structure and function. The
essential histone variant H2A.Z affects various DNA-based
processes via poorly understood mechanisms. Here, we determine
the comprehensive interactome of H2A.Z and identify PWWP2A as
a novel H2A.Z-nucleosome binder. PWWP2A is a functionally
uncharacterized, vertebrate-specific protein that binds very tightly
to chromatin through a concerted multivalent binding mode. Two
internal protein regions mediate H2A.Z-specificity and nucleosome
interaction, whereas the PWWP domain exhibits direct DNA bind-
ing. Genome-wide mapping reveals that PWWP2A binds selectively
to H2A.Z-containing nucleosomes with strong preference for
promoters of highly transcribed genes. In human cells, its deple-
tion affects gene expression and impairs proliferation via a mitotic
delay. While PWWP2A does not influence H2A.Z occupancy, the
C-terminal tail of H2A.Z is one important mediator to recruit
PWWP2A to chromatin. Knockdown of PWWP2A in Xenopus results
in severe cranial facial defects, arising from neural crest cell
differentiation and migration problems. Thus, PWWP2A is a novel
H2A.Z-specific multivalent chromatin binder providing a surprising
link between H2A.Z, chromosome segregation, and organ develop-
ment.
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Introduction
H2A.Z, an evolutionary highly conserved histone H2A variant
(Iouzalen et al, 1996), is implicated in fundamental biological
processes, such as transcriptional regulation, cell cycle control, and
DNA repair (Santisteban et al, 2000; Meneghini et al, 2003;
Rangasamy et al, 2004; Kalocsay et al, 2009; Weber et al, 2010; Zovkic
et al, 2014), as well as cancer initiation and progression (Svotelis
et al, 2010; Dryhurst et al, 2012; Valdes-Mora et al, 2012; Kim et al,
2013). In flies, frogs, and mice, H2A.Z is required for early develop-
ment and survival (van Daal & Elgin, 1992; Iouzalen et al, 1996;
Faast et al, 2001). Vertebrates contain two non-allelic H2A.Z-
encoding genes (H2AFZ and H2AFV), whose protein products
(H2A.Z.1 and H2A.Z.2) differ in only three amino acids (Eirin-Lopez
et al, 2009). Alternative splicing of H2A.Z.2 mRNA in primates gives
rise to H2A.Z.2.1 (for simplicity reasons referred to as H2A.Z.2) and
the nucleosome-destabilizing H2A.Z.2.2 isoform (Bonisch et al,
2012; Wratting et al, 2012). Interestingly, we recently found
H2A.Z.2 to contribute to metastatic melanoma progression through
regulation of E2F-target gene expression promoting cell proliferation
(Vardabasso et al, 2015). Despite progress in recognizing H2A.Z’s
contributions to DNA-based processes, little is known about the
underlying mechanisms. H2A.Z- and H2A-containing nucleosome
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stabilities seem to be rather similar (Bonisch & Hake, 2012), but
their molecular surfaces differ (Suto et al, 2000). The acidic patch, a
C-terminal region that is further extended in H2A.Z in comparison
with H2A, is important for H2A.Z chromatin deposition (Latrick
et al, 2016) and is hypothesized to also play a role in the recruit-
ment of chromatin context-dependent readers that in turn differen-
tially modify surrounding chromatin regions (Suto et al, 2000).
In order to identify such an H2A.Z network, we utilized a label-
free quantitative mass spectrometry approach using two different
human cell lines. We found > 35 proteins constituting readers, writ-
ers, and erasers of histone marks, as well as novel chromatin inter-
actors to be significantly enriched on H2A.Z- versus H2A-containing
nucleosomes. One of those is PWWP2A, a functionally uncharacter-
ized vertebrate-specific protein containing a conserved PWWP
domain. PWWP2A is found at H2A.Z-containing transcriptional
start sites of highly expressed genes and an internal amino acid
stretch is sufficient to confer H2A.Z-specificity, as well as nucleo-
some binding in vivo. Strong chromatin affinity in vivo depends on
both the internal stretch and the highly conserved PWWP domain,
which functions as a DNA interaction module, revealing a multiva-
lent binding mode. H2A.Z chromatin occupancy does not depend
on PWWP2A, while H2A.Z via its C-terminal tail is one important
feature for strong PWWP2A chromatin association. Depletion of
PWWP2A in human cells results in impaired cellular proliferation
due to a block in metaphase-anaphase transition. While chromoso-
mal passenger complex members are unaffected, loss of PWWP2A
results in the deregulation of many genes involved in metabolism
and morphology. In X. tropicalis, PWWP2A is expressed early
during development in the neuroectoderm and neural crest. Knock-
down of frog PWWP2A results in severe defects in head develop-
ment, arising from neural crest cell migration and differentiation
problems. This phenotype can be rescued by human PWWP2A
protein variants that recognize H2A.Z. In summary, our study iden-
tifies PWWP2A as an H2A.Z-specific multivalent chromatin binder
that participates in regulating cell-specific crucial gene expression
programs.
Results
Identification of PWWP2A as novel H2A.Z-nucleosome interactor
Previously, we employed a label-free quantitative mass spectrome-
try approach and identified H2A.Z mononucleosome binders in the
metastatic melanoma cell line SK-mel147 stably expressing GFP and
GFP-tagged H2A variants (Vardabasso et al, 2015). Further experi-
ments in this system as well as in HeLa Kyoto (HeLaK) cells
(Fig EV1A and B) allowed us to quantitate candidate protein bind-
ing and to determine cell type-specific H2A.Z network differences
(Fig EV1C–E). Upon comparison between SK-mel147 biological
replicates, we identified 44 proteins that were significantly enriched
on H2A.Z.1 or H2A.Z.2 nucleosomes compared to H2A-containing
ones (Figs 1A and EV1C). Almost all members of the H2A.Z-specific
SWR1-related chaperone complex SRCAP (Ruhl et al, 2006) were
found, confirming the sensitivity and specificity of our approach
(Fig 1A and B). In contrast to SRCAP, only EP400 and TRRAP, the
largest subunits of the second multicomponent H2A.Z deposition
complex p400/TIP60 (Cai et al, 2005), were precipitated, suggesting
that this complex either binds only transiently to chromatin or
requires larger chromatin domains than just mononucleosomes. We
also found BRD2, which has previously been shown in 293T cells to
preferentially bind hyperacetylated H2A.Z nucleosomes (Draker
et al, 2012) to be a specific interactor, further verifying our method
(Vardabasso et al, 2015). In concordance with our hypothesis of
H2A.Z being a recruiter of many chromatin-altering proteins, we
identified repressive as well as activating histone-modifying
complexes. Members of the H3K4me3-catalyzing MLL complex as
well as the H3K9me2 and H3K36me3 demethylases PHF2 and
KDM2A, respectively, were specific interactors, likely accounting for
the characteristic histone posttranslational modification (PTM) pro-
file of H2A.Z nucleosomes (Fig 1C). Together, the identification of
complexes involved in diverse DNA-based processes supports our
hypothesis of H2A.Z being a general but selective recruitment factor
of chromatin-modifying proteins.
We chose to further investigate the so far functionally uncharac-
terized vertebrate-specific PWWP2A protein because of its interest-
ing domain structure and its presence in previous H2A.Z-pull-down
experiments (Draker et al, 2012). PWWP2A belongs to a group of
proteins containing a PWWP domain that was first identified in
Wolf-Hirschhorn syndrome candidate 1 (WHSC1) (Stec et al, 2000).
First, we confirmed PWWP2A interaction with H2A.Z nucleosomes
by immunoblots applying native GFP-variant mononucleosome IPs
(mono-IPs; Fig 1D). Next, we cloned PWWP2A from SKmel-147
cDNA and generated HeLaK cell lines stably expressing N-terminally
GFP-tagged PWWP2A (Fig EV1F). As suspected, GFP-PWWP2A was
predominantly found in the nucleus (Fig EV1G). Although most of
the protein was relieved from chromosomes during mitosis, a frac-
tion of it remained stably associated with chromatin, assuming a
strong chromatin binding ability of a sub-pool of PWWP2A. Native
mono-IPs using these cells independently confirmed PWWP2A’s
specificity for H2A.Z nucleosomes (Fig 1E). Additionally, binding of
endogenous PWWP2A to endogenous H2A.Z and not to H2A nucle-
osomes confirmed our findings (Fig EV1H). In summary, we have
identified PWWP2A as a novel and functionally uncharacterized
H2A.Z-nucleosome interactor.
Multivalent binding mode of PWWP2A enables H2A.Z-nucleosome
binding specificity as well as strong chromatin interaction
Intrigued by PWWP2A’s specific and strong H2A.Z interaction, we
used recombinant GST-tagged PWWP2A and mononucleosomes
isolated from HeLaK cells for in vitro pull-down assays, which effi-
ciently pulled-down tagged and untagged H2A.Z-containing nucleo-
somes and reproduced our previous results (Fig 2A and B). Further,
GST-PWWP2A was able to interact with recombinant nucleosomes,
thereby showing a higher affinity to H2A.Z than to H2A (Fig 2C)
verifying a direct H2A.Z-nucleosome binding specificity. Human
PWWP2A contains two N-terminal proline-rich stretches (P1, P2)
and a C-terminal serine-rich region (S) followed by a conserved
PWWP domain (Appendix Fig S1A). Since the highly conserved
PWWP domain plays a role in chromatin recognition (Qin & Min,
2014), we generated a PWWP domain deletion mutant (DPWWP)
and a construct entirely consisting of the PWWP domain and the
last C-terminal amino acid stretch (PWWP) (Fig 2D, top). Interest-
ingly, both deletion mutants were able to pull-down HeLaK-derived
nucleosomes (Fig 2D, bottom), suggesting that at least two separate
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domains participate in chromatin interaction. IPs with additional
recombinant GST-PWWP2A deletion proteins (Fig 2E and
Appendix Fig S1B) determined the domain sufficient for H2A.Z-
nucleosome interaction to be an internal (I) stretch between the P2
and S regions. Surprisingly, this domain could be further divided
into an N-terminal region (IN) necessary for nucleosome binding
and a C-terminal part (IC) mediating H2A.Z-specificity (Fig 2F and
G, and Appendix Fig S1C and D). This is a unique and so far unde-
scribed feature as BLAST searches did not find any sequence





































































































































































































Figure 1. PWWP2A is a novel H2A.Z mononucleosome binder.
A Heatmap of significant outliers from pull-downs analyzed by label-free MS-based proteomics with mononucleosomes derived from Skmel-147 (two independent
experiments: SK1 and SK2; see also Vardabasso et al, 2015 for first replicate) or HeLaK (HK) cells stably expressing GFP-H2A (H2A), GFP-H2A.Z.1 (Z.1), or GFP-H2A.Z.2
(Z.2), normalized to H2A. Scale bar: log2-fold. See also Fig EV1A–E for details on experimental procedure and verification of results, and Datasets EV1–EV3 for
detailed lists of H2A.Z-binders.
B Immunoblotting of SRCAP complex-specific member ZNHIT1 upon SK-mel147 GFP, GFP-H2A, GFP-H2A.Z.1, or GFP-H2A.Z.2 mono-IPs. GFP served as control.
C, D Immunoblotting of different histone PTMs (C) or PWWP2A (D) upon GFP, GFP-H2A, GFP-H2A.Z.1, or GFP-H2A.Z.2 mono-IPs. Notice the different sizes of endogenous
PWWP2A protein (see also Figs EV1H and EV4C), possibly due to different modifications.
E Immunoblots of GFP-H2A.Z.1 or GFP-PWWP2A mono-IPs detecting endogenous H3, H2A, or H2A.Z. Notice enrichment of H2A.Z in comparison with H2A in GFP-
PWWP2A pull-down. See also Fig EV1F–H for generation and characterization of GFP-PWWP2A cell lines and endogenous pull-down.
Source data are available online for this figure.
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Next, we wondered how the PWWP domain contributes to
further chromatin association. Recently, PWWP domains have been
shown to be DNA and/or histone PTM binders (Chen et al, 2004;
Yang & Everett, 2007). Based on the PWWP domain solution struc-
ture of PWWP2B (Qin & Min, 2014), a close homolog of PWWP2A,
we modeled the 3D structure of the PWWP domain of PWWP2A
(Fig 3A). The electrostatic potential of the solvent-accessible surface
revealed an overall enrichment in basic residues, suggestive of
DNA-binding potential (Fig 3A). Indeed, PWWP2A’s PWWP
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H2A.Z-specificity directly (Appendix Fig S2A). Thus, PWWP2A
interacts with chromatin via a multivalent binding mode with sepa-
rated nucleosome interaction, H2A.Z-specificity, and DNA-binding
domains.
Next, we determined PWWP2A’s chromatin association in vivo
by Fluorescence Recovery After Photobleaching (FRAP) experi-
ments. GFP-PWWP2A showed an extremely slow recovery curve,
suggesting that it is stably bound to chromatin (Fig 3C and
Appendix Fig S2B–E). Constructs containing either the internal or
the PWWP domain or a deletion of the PWWP domain (DPWWP)
featured much faster recovery kinetics than wild-type PWWP2A
(Fig 3C, Appendix Fig S2E), further supporting a multivalent chro-
matin-binding mode. PWWP2A deletion protein consisting only of
the internal, serine-rich and PWWP domains (I_S_PWWP), showed
◀ Figure 2. Two separate internal regions of PWWP2A confer nucleosome binding and H2A.Z-specificity.A Pull-downs of GST or GST-PWWP2A with mononucleosomes (input) derived from HeLaK cells. Precipitated recombinant GST proteins and histones are detected with
Coomassie blue staining and H2A and H2A.Z with specific antibodies in immunoblots. * indicates right sizes of purified and precipitated GST and GST-PWWP2A.
B Immunoblots of GST-PWWP2A IPs with mononucleosomes derived from HeLaK cells stably expressing GFP-H2A (H2A), GFP-H2A.Z.1 (Z.1), or GFP-H2A.Z.2 (Z.2).
C Representative competitive EMSA using recombinant H2A (bottom)- or H2A.Z (top)-containing nucleosomes incubated with indicated increasing concentrations of
GST-PWWP2A. GST alone served as negative control. * indicates nucleosome; ** indicates nucleosome-GST-PWWP2A complex.
D Schematic representation of recombinant GST-tagged PWWP2A and PWWP domain deletion (DPWWP) and PWWP domain only (PWWP)-containing constructs (top)
used in cell-derived mono-IPs followed by Coomassie staining and immunoblotting (bottom). * indicates respective GST proteins. Notice that both the PWWP domain
alone as well as the PWWP-deletion protein are able to interact with nucleosomes, indicating at least two independent nucleosome binding sites within PWWP2A.
E Schematic representation of recombinant GST-PWWP2A deletions (top) used in cell-derived mono-IPs followed by Coomassie and immunoblotting (bottom). See also
Appendix Fig S1B for protein purification.
F Schematic representation of recombinant GST-PWWP2A internal deletions (top) used in cell-derived mono-IPs followed by Coomassie and immunoblotting (bottom).
See also Appendix Fig S1C and D for protein purification and further IPs.
G IPs as described in (F) with mononucleosomes derived from HeLaK cells stably expressing GFP-H2A and GFP-H2A.Z isoforms detected with anti-GFP antibody.












































Figure 3. Multivalent binding mode of PWWP2A enables high-affinity chromatin interaction.
A The electrostatic surface potential (ESP) of the published structure of the PSIP DNA-binding PWWP domain (Eidahl et al, 2013) was calculated (left), and the
PWWP2A-PWWP domain (right) was modeled based on published PWWP2B 3D structure (Qin & Min, 2014). ESP color values are in units of kcal/(mol*e) at 298 K.
Three representative views of the ESP of the PWWP2A PWWP domain (right).
B Representative EMSA using Cy-5 labeled 75-bp dsDNA and indicated increasing concentrations of GST-PWWP domain. *: free DNA; **: shifted PWWP-DNA complex.
See also Appendix Fig S2A for H2A.Z-independence of PWWP domain in nucleosome interaction.
C FRAP quantification curves of average GFP signal relative to fluorescence signal prior to bleaching from transiently expressed GFP (negative control), GFP-tagged
histones, and GFP-tagged PWWP2A mutants (n = 5–14). See also Appendix Fig S2B for FRAP experiments comparing recovery signals of different chromatin binding
proteins to GFP-PWWP2A, as well as Appendix Fig S2C–E for FRAP analyses of stable and transient GFP and GFP-tagged proteins expressing HeLaK cells.
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an identical recovery curve as full-length PWWP2A (Fig 3C). Thus,
concerted low-affinity interactions of the internal region and the
PWWP domain are needed for an exceptionally strong chromatin
association paired with H2A.Z-nucleosome specificity.
PWWP2A predominantly localizes to the promoter region of
highly transcribed genes
To determine PWWP2A’s chromatin occupancy in comparison with
H2A.Z-enriched sites genome-wide, we performed native chromatin
immunoprecipitation followed by high-throughput sequencing
(nChIP-seq) using stable cell lines expressing GFP-tagged H2A.Z
isoforms or GFP-PWWP2A and found that PWWP2A was particu-
larly enriched at promoters and 50-UTR sites (Figs 4A and EV2A).
PWWP2A overlapped to 77 and 66% with H2A.Z-containing peaks
at promoter or non-promoter regions, respectively (Fig 4B). Inter-
estingly, both H2A.Z.1 and H2A.Z.2 peaks showed an enrichment
of PWWP2A at promoter regions, but only little overlap with
PWWP2A at non-promoter sites (Fig 4C), suggesting that H2A.Z is
one main but not the sole determinant for PWWP2A’s site speci-
ficity. Heatmap alignment revealed a strong correlation of PWWP2A
and H2A.Z variants with highly transcribed genes in euchromatic
H3K4me3-positive regions (Figs 4D and EV2B). Both H2A.Z vari-
ants and PWWP2A were located at the 1 and +1 nucleosomes at
transcriptional start sites (TSSs; Fig 4E). Interestingly, PWWP2A
also accumulated at the nucleosome-depleted region (NDR), possi-
bly recognizing free DNA via its PWWP domain and protecting it
from MNase digestion. We conclude that PWWP2A interacts specifi-
cally with H2A.Z nucleosomes at the TSS of highly transcribed
genes.
PWWP2A depletion leads to deregulation of gene expression and
results in a proliferation defect caused by a metaphase-
anaphase block
Next, we investigated PWWP2A’s biological function by RNA inter-
ference (RNAi) in HeLaK cells using two independent siRNAs that
efficiently downregulated PWWP2A mRNA (Fig 5A) as well as
protein (Fig 5B). Having PWWP2A found predominantly at the TSS
of actively transcribed genes, we wanted to know whether it is
involved in the regulation of gene expression. Indeed, RNA-seq of
PWWP2A-depleted cells identified ~600 genes to be deregulated
(Fig 5C). Gene ontology (GO) analysis revealed an enrichment of
genes involved in developmental process regulation and cell
morphogenesis (Appendix Fig S3). With so many genes deregulated
and important cellular processes possibly affected, we wondered
about phenotypic and functional consequences of PWWP2A
reduction. Interestingly, we noticed that fewer cells (Fig 5B) with
overall slightly enlarged nuclei (Fig EV3A) were present upon
knockdown, correlating with a reduction in cell proliferation
(Fig 5D).
Analysis of cell cycle phases by flow cytometry of propidium
iodide (PI)-stained cells revealed an accumulation in G2/M phase
cells upon PWWP2A knockdown (Fig 6A and B). Subsequent co-
staining with PI and H3S10ph antibody showed that PWWP2A
depletion leads to an increase in mitotic cells (Fig 6C and D), espe-
cially enriching for prometaphase and depleting anaphase cells as
demonstrated by immunofluorescence microscopy of H3S10ph-
positive cells (Figs 6E and EV3B). Real-time-lapse microscopy imag-
ing confirmed a halt of PWWP2A-depleted cells in mitosis for up to
10 h, while control cells traversed through mitosis in < 1.5 h
(Fig 6F and Movies EV1–EV4). PWWP2A RNAi cells repeatedly
shuffled back and forth between prometaphase and metaphase
unable to keep all chromosomes at the equatorial plate. In agree-
ment with the observation that chromosomes were able to move,
we did not find any changes in centromere and kinetochore forma-
tion (Fig EV3C). Further, although tubulin spindles were generated
and contributed to the moving motion of chromosomes, they
showed a slight abnormal morphology (Fig EV3D). Interestingly,
this mitotic phenotype strongly copies the previously described, but
mechanistically not understood, mitotic defect observed in H2A.Z
double knockout vertebrate cells (Kusakabe et al, 2016), thus identi-
fying PWWP2A as a possible mediator of the H2A.Z-dependent cell
cycle progression phenotype.
PWWP2A does not influence H2A.Z occupancy, while H2A.Z’s
C-terminal tail contributes to PWWP2A chromatin recruitment
One possible explanation for the strong cell cycle progression
phenotype upon PWWP2A loss could be the result of changes in
H2A.Z occupancy due to either defects in its deposition or an
increase in chromatin destabilization. However, H2A.Z chromatin
binding ability was not affected upon PWWP2A depletion (Fig 7A,
Appendix Fig S4A). Accordingly, GFP-H2A.Z.1 nChIP-seq upon
PWWP2A knockdown revealed only small differences in H2A.Z
peak heights (Figs 7B and EV4A and B) and no effect on global
H2A.Z levels (Fig EV4C). Given that the observed reduction was
found on PWWP2A-bound as well as non-bound sites, it is highly
likely that general cellular changes, possibly due to defects in mito-
sis, and not a specific H2A.Z-depositioning defect, are the cause of
this phenomenon. Likewise, overexpression of Cherry-tagged
PWWP2A (Ch-PWWP2A) in GFP-H2A.Z expressing HeLaK cells
(Appendix Fig S4B) did not influence H2A.Z occupancy (Fig EV4D).
Based on these observations, we speculate that PWWP2A is not
▸Figure 4. PWWP2A binds H2A.Z nucleosomes at TSS of actively transcribed genes.A Log2-enrichment plot representing genomic regions after GFP-PWWP2A (blue), GFP-H2A.Z.1 (red), GFP-H2A.Z.2 (orange), and H3K4me3 (purple) nChIP-seq. Shown are
two biological replicates for each nChIP. See also Fig EV2A for representative genome browser captures.
B Venn diagrams displaying total (left) or promoter-occupying (right) peaks of HeLaK GFP-PWWP2A, GFP-H2A.Z.1, and GFP-H2A.Z.2. Promoters are defined as
3 kb < TSS < +1 kb.
C Distribution of overlapping peaks between GFP-PWWP2A (top), GFP-H2A.Z.1 (middle), and GFP-H2A.Z.2 (bottom) nChIP-seq data of promoter (left) and non-promoter
(right) regions according to (B).
D Heatmap of nChIP-seq peaks at transcriptional start sites (TSS) sorted for expression level (top: high expressed, bottom: low expressed genes).
E Correlation of GFP-PWWP2A (green), -H2A.Z.1 (blue), -H2A.Z.2 (brown), and H3K4me3 (purple) mean coverage signals at TSS of expressed genes. See Fig EV2B for GFP-
PWWP2A localization at euchromatic regions.
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needed for H2A.Z targeting, while on the other hand H2A.Z might
be one important requirement for PWWP2A’s recruitment to specific
chromatin regions.
Indeed, depletion of the IC region in PWWP2A (DIC), which medi-
ates H2A.Z-specificity (Fig 2F and G), resulted in increased mobility in
FRAP (Fig 7C, Appendix Fig S4C), suggesting that H2A.Z is one impor-
tant but not the sole mediator of PWWP2A chromatin association.
Accordingly, performing IPs with recombinant GST-PWWP2A and
mononucleosomes derived from an inducible H2A.Z double knock out
(DKO, both H2A.Z.1 and H2A.Z.2 isoforms are targeted) DT40 chicken
cell line (Maruyama et al, 2012; Kusakabe et al, 2016) resulted in a
diminished, but due to its multivalent binding mode not abolished,
mononucleosome-binding ability of PWWP2A (Fig 7D).
Next, we determined the region in H2A.Z that mediates PWWP2A
specificity. In particular the C-terminal acidic patch of H2A.Z has been
proposed to provide a variant-specific binding platform for nuclear
proteins (Suto et al, 2000). We therefore incubated recombinant
PWWP2A with mononucleosomes derived from HeLaK cells tran-
siently expressing Flag-tagged H2A, H2A.Z.1, or C-terminal deleted
H2A.Z.1 (H2A.ZDC) (see Fig EV4E for rescue experiments implying
proper chromatin incorporation). Indeed, depletion of the nine unique
C-terminal amino acids in H2A.Z keeping the extended acidic patch
intact led to a reduction in PWWP2A binding, resembling the binding
ability of canonical H2A (Fig 7E). In conclusion, PWWP2A is not
needed for proper H2A.Z occupancy, while H2A.Z via its C-terminal
tail is partially required for PWWP2A chromatin binding.
PWWP2A is crucial for neural crest cell differentiation and
migration during Xenopus laevis development
As PWWP2A depletion also affected gene programs of develop-
mental processes in HeLaK cells (Appendix Fig S3), we next asked
A B
C D
Figure 5. PWWP2A depletion in HeLaK cells leads to alterations in gene expression programs and a proliferation defect.
A PWWP2A expression analysis by qPCR 2 days after knockdown with two independent siRNAs (PW#1, PW#2) using two different primer pairs (PW_2: recognizes main
splice product; PW_all: recognizes all predicted splice forms). Luciferase siRNA (Luci) and non-transfected wild-type (wt) cells were used as controls. All data were
normalized to HPRT1/HMBSS expression and depicted as % of luci transfectants. Error bars indicate SEM of four biological replicates.
B IF microscopy analysis of cells treated as described in (A). Cells were stained with DAPI to visualize DNA (top) and anti-PWWP2A antibody (bottom). Scale
bars = 10 lm. Notice slight increase in nuclear size upon PWWP2A depletion (quantification in Fig EV3A).
C Scatter plot summarizing genes up- (top red) or down-regulated (bottom red) upon PWWP2A depletion (blue dots indicate different PWWP2A RNA isoforms) as
determined by RNA-seq. See also Appendix Fig S3 for GO term analysis of deregulated transcripts.
D Growth curve of HeLaK cells after RNAi (red: PWWP2A siRNAs, black: wt and luciferase control siRNAs). Error bars indicate SEM of three independent biological replicates.
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whether PWWP2A plays any role in vivo during organismal devel-
opment. We chose the African clawed frogs X. laevis and X. tropi-
calis as model systems. Both species contain a PWWP2A gene
whose protein sequence is strongest conserved in the internal, the
serine-rich region, and the PWWP domain (Appendix Fig S5).
Whole-mount RNA in situ hybridization in various developmental
stages indicated endogenous X. tropicalis PWWP2A (XtPWWP2A)
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Figure 6. PWWP2A is crucial for proper mitosis progression.
A Cell cycle analysis of PI-stained HeLaK RNAi cells using flow cytometer.
B Quantification of experiments described in (A). Percentages of cells in G1, S, or G2/M phases 3 days after RNAi. Error bars indicate SEM of five independent biological
replicates.
C Flow cytometry dot-plots of HeLaK cells co-stained with PI and H3S10ph antibody 3 days after RNAi to distinguish between G2 and M phase cells.
D Quantification of experiments described in (C). Percentages of cells in G2 or M phases 3 days after RNAi. Error bars indicate SEM of three independent biological
replicates.
E Quantification of mitotic phases 2 days after RNAi by visually distinguishing morphological characteristics of H3S10ph-positive cells. Error bars indicate SEM of four
independent biological replicates. See also Fig EV3B–D for stainings and chromosome spreads of control and RNAi cells.
F Selected panels from live cell time-lapse experiments (see also Movies EV1–EV4) of wt, luciferase control, and PWWP2A-depleted HeLaK cells expressing GFP-H2A for
visualization of chromatin for 4 h starting from nuclear breakdown at prophase. Scale bars = 10 lm.
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stages (Fig EV5A), similarly to the H2A.Z mRNA profile (Ridgway
et al, 2004). Subsequently, XtPWWP2A transcripts became
enriched in the neuroectoderm, notably in neural folds, retina, and
cranial neural crest. In tailbud stages, XtPWWP2A remained
broadly expressed with a clear anterior bias. We investigated the
biological impact of XtPWWP2A on development by protein-
knockdown with a specific PWWP2A translation-blocking Morpho-
lino oligonucleotide (pwMO) (Fig EV5B) by injecting control
(CoMO) or pwMO into one blastomere of 2-cell stage Xenopus
laevis embryos. All embryo cohorts developed normally
A B 22343 H2A.Z only peaks
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Figure 7. PWWP2A does not influence H2A.Z occupancy but C-terminal tail of H2A.Z mediates PWWP2A nucleosome binding.
A FRAP quantification curves of average GFP signal relative to fluorescence signal prior to bleaching from HeLaK stably expressing GFP-H2A or GFP-H2A.Z.1 2 days after
control (wt, Luci) or PWWP2A (PW#1, PW#2) knockdown (n = 9–19) (see Appendix Fig S4A for FRAP experiments).
B Venn diagram displaying sole GFP-H2A.Z.1 (left, 22,343 peaks) or overlapping with PWWP2A (left, 18,227 peaks) nChIP-seq signals in control (ctrlii, Luci; dark blue) or
PWWP2A-depleted (PW#1, PW#2; red) background (see also Fig EV4A and B).
C Schematic representation of PWWP2A and IC region deletion (DIC) (top). FRAP quantification curves (bottom) as shown and described in Fig 3C with the addition of
GFP-DIC (n = 16) (see also Appendix Fig S4C for FRAP IF pictures).
D Immunoblotting of endogenous H3 and H2A.Z (verification of tetracycline (tet)-induced knockout efficiency) upon IP of mononucleosomes derived from WT or H2A.Z
DKO DT40 cells with recombinant GST (negative control) or GST-PWWP2A. Notice that less H3 is pulled down with PWWP2A when H2A.Z is depleted.
E Schematic representation of Flag-tagged chicken H2A, H2A.Z, and H2A.Z C-terminal deletion mutant (H2A.ZDC) (top, left). Note indication of acidic patch in H2A (gray
box) and extended acidic patch in H2A.Z (black box). After transient transfection of HK cells with Flag-constructs, derived mononucleosomes were incubated with
recombinant GST or GST-PWWP2A and binding efficiency and variant-specificity was tested in immunoblots with anti-Flag antibody (left). Right: Quantification of
signal intensities of immunoblots using Image Studio Lite Ver 5.2 (LI-COR). Error bars indicate SEM of four independent replicates. See Fig EV4E for partial growth
rescue of Flag-H2A.ZDC in DKO cells.
Source data are available online for this figure.
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throughout neurulation. However, during tadpole stages a strong
delay in head differentiation, most visible in the eye, appeared in
the pwMO-injected side (Fig 8A). The lack of retinal tissue
combined with a reduced head size was observed in nearly 80%
of the pwMO-injected embryos (Table EV1). This phenotype was
specific and PWWP2A’s function evolutionary conserved, because
coinjection of the full-length human GFP-PWWP2A mRNA, which
was not affected by pwMO, restored wild-type head morphology in
the majority of animals (65%) (Fig 8A, Table EV1). Interestingly,
the_I_S_PWWP and DPWWP protein variants restored normal
head development with nearly the same efficiency as the full-
length protein, while the DIC variant did not revert the pwMO
phenotype. These findings suggest that PWWP2A exerts its func-
tions in head development through interaction with H2A.Z.
Furthermore, injection of pwMO into embryos of the closely
related X. tropicalis caused a comparable morphological phenotype
(Fig EV5C). As development proceeded, the majority of the
PWWP2A morphant embryos managed to form small eyes with
lenses, but they failed to recover a bilaterally symmetric head and









































































Figure 8. PWWP2A is essential for Xenopus eye, head, and brain development.
A Left side: One-cell of two-cell stage Xenopus laevis embryos was injected with either control (CoMO) or pwwp2a-specific (pwMO) morpholino. For rescue experiments,
pwMO morphant embryos were coinjected with mRNAs encoding either GFP-tagged full-length or variant human PWWP2A proteins, as indicated. Injected body sites
were identified by Alexa 594 red fluorescence, while GFP fluorescence indicates synthesis of coinjected human PWWP2A protein variants. Panels display side views of
representative embryos from the indicated conditions; numbers indicate penetrance of the major morphological phenotype over total embryos inspected. Right side:
Quantification of the percentage of the observed phenotype, that is, malformation of head structures and eyes. Error bars indicate SEM of at least three independent
biological replicates (see also Table EV1). *P ≤ 0.05 (Student’s t-test, two-sided, unpaired).
B Whole-mount RNA in situ hybridization assays with probes against rx1 (anterior view) and twist (dorsoanterior view) in either CoMO- or pwMO-injected embryos at
neurula stage. The rx1 gene is induced normally; the cranial neural crest marker twist is diminished on the pwMO-injected side (91% affected), which is partially
restored by coinjection of full-length PWWP2A mRNA (60% affected). Numbers indicate penetrance of the depicted molecular phenotype over total embryos
inspected. Right: Quantification of the percentage of misexpression of twist mRNA in controls compared to pwMO morphant and rescue condition. Error bars indicate
SEM of three independent biological replicates. *P ≤ 0.05 (Student’s t-test, two-sided, unpaired).
C Representative images of dissected facial cartilage from CoMO- or pwMO-injected embryos visualized by Alcian blue staining. (+) indicates injected body side.
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Since the morphological phenotype coincided with the region of
high expression of PWWP2A mRNA, we investigated the expres-
sion of eye and cranial neural crest (CNC) markers in half-injected
morphant embryos. At mid-neurula stages, the retinal homeobox
gene rx1 is expressed in a symmetric anterior domain of the
prospective eye field (Casarosa et al, 1997). Rx1 mRNA staining
was indistinguishable between CoMO- and pwMO-injected embryos
(Fig 8B), indicating that the observed defect in eye-formation
occurs downstream of eye field induction. During neurulation,
cranial neural crest cells are induced at the border of the anterior
neural plate, migrate ventrally shortly after, and differentiate ulti-
mately into cartilage and bones (LaBonne & Bronner-Fraser, 1998;
Theveneau & Mayor, 2012). At the tadpole stage, the number of
cells expressing the CNC regulatory gene twi was reduced in
pwMO-injected embryos, a phenotype that was partially rescued
by coexpression of the human full-length PWWP2A protein
(Fig 8B). To corroborate this result, we performed Alcian blue
staining of the cranial cartilage at the tadpole stage. In contrast to
control morphants, the cartilage in the PWWP2A-morphant side of
embryos was strongly reduced in mass and disorganized, most
obviously within the branchial arches (Fig 8C). We conclude that
the reduced CNC formation in PWWP2A-depleted embryos trans-
lates into a permanent defect in cartilage formation. These results
identify an essential role for PWWP2A in cranio-facial morpho-
genesis.
Discussion
H2A.Z is involved in all DNA-related processes by so far not
well-understood mechanisms. We and others (Hu et al, 2013)
hypothesized that this evolutionary conserved histone variant
serves as a binding platform for distinct chromatin-modifying
complexes whose recruitment depends on additional chromatin
surroundings. In our native quantitative MS approach, we used
high-stringency settings to enrich for variant-specific binders and
excluded proteins that also interacted strongly with H2A nucleo-
somes. Accordingly, we identified some previously found
proteins, like BRD2 (Draker et al, 2012) and members of the
SRCAP complex, as well as several transcription factors and
histone-modifying proteins/complexes While we were able to
pull-down the H2A.Z-specific chaperone complex SRCAP, we only
managed to identify the two largest subunits of the other H2A.Z
chaperone complex p400/TIP60 (EP400 and TRRAP), but not
other unique members. This finding raises the question why these
two chaperone complexes that evolved from the yeast SWR1
complex and have been suggested to both participate in H2A.Z
nucleosome exchange bind so differently to chromatin. It is possi-
ble that they function in distinct processes, as the p400/TIP60
complex has been shown to participate in DNA damage repair
(reviewed in Jacquet & Cote, 2014), while SRCAP is important for
H2A.Z deposition in gene regulation, as, for example, in muscle
differentiation (Cuadrado et al, 2010). Alternatively, the p400/
TIP60 complex together with ANP32E rather mediates H2A.Z
removal and is therefore not stably associated with H2A.Z nucleo-
somes (Mao et al, 2014; Obri et al, 2014), or it requires larger
chromatin domains than just one nucleosome for binding. The
identification of histone-modifying complexes involved in gene
activation (e.g., MLL) and repression (e.g., HDAC1/2), supports
the idea of H2A.Z being a recruitment platform for many proteins
that participate in different aspects of gene regulation. We suspect
that these complexes are not recruited to the same regions but
are found at distinct H2A.Z sites in the genome, but where they
are located and how they are recruited to these sites needs to be
determined in future experiments.
Our studies identified the uncharacterized vertebrate-specific
PWWP2A protein to be a novel H2A.Z-nucleosome binder that
interacts via the variant’s C-terminus. Surprisingly, the extended
acidic patch required for proper targeting and deposition and being
proposed to be an interaction hub (Suto et al, 2000) is not suffi-
cient for PWWP2A nucleosome binding. Interestingly, the short
nine amino acid long C-terminal stretch that is required for
PWWP2A binding is a flexible region that extends out of the nucle-
osome core particle, it is different from H2A and apparently only
conserved between vertebrates that also contain PWWP2A. As
PWWP2A interacts with both H2A.Z isoforms that differ in the last
residue (valine versus alanine) PWWP2A’s interaction sequence
appears to be “GKKGQQKT” and includes residues that can be
ubiquitylated (Sarcinella et al, 2007). Whether this modification
that marks transcriptionally silent facultative heterochromatin has
any effect on PWWP2A binding and function remains to be
elucidated.
PWWP2A might act as a “mediator” or “adapter” between H2A.Z
nucleosomes and further chromatin-modifying proteins, because it
apparently does not contain any enzymatic active domains. In line
with this hypothesis is our finding that PWWP2A is not needed for
proper H2A.Z deposition and chromatin occupancy, while H2A.Z is
at least partially required for PWWP2A nucleosome binding.
PWWP2A specifically recognizes H2A.Z nucleosomes at the TSS of
active genes, while most H2A.Z at non-promoter sites are depleted
of PWWP2A. These data suggest that PWWP2A needs an additional
so far unknown signal that either keeps it at the TSS or prevents its
recruitment to most H2A.Z non-promoter regions. It is possible that
the NDR region is recognized by the PWWP domain and is thereby
one of the specificity determinant(s) as such a long stretch of free
DNA is characteristic for TSS regions and might not occur at non-
promoter intergenic sites. Alternatively or additionally, another not
yet identified chromatin feature, maybe histone PTMs that can be
recognized via a conserved aromatic cage in the PWWP domain,
confers extra specificity.
We have shown that PWWP2A binds to chromatin utilizing at
least three different domains that confer H2A.Z variant-specificity,
nucleosome interaction, and DNA binding. Such a combinatorial
binding mode might enable the recognition of different sites with
different affinities and therefore distinct modes of regulation.
Although PWWP2A is found predominantly at H2A.Z genomic
sites, non-promoter regions containing H2A.Z are mostly devoid
of PWWP2A. This suggests that H2A.Z is a primary determinant
for PWWP2A recruitment, but additional signals (possible free
DNA and/or PTMs) confer a stable, high-affinity association. As
PWWP2A is predominantly found at the TSS of highly expressed
genes, it is not surprising that its depletion affects gene expres-
sion programs and has profound consequences on cellular
processes. We speculate that depending on the cell type and
developmental stage, PWWP2A is involved in ensuring proper
gene expression levels and any interference with this process
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results in cell type-specific defects. HeLaK cells, which are immor-
tal, aneuploid tumor cells with a high proliferation capacity might
therefore be strongly affected in mitotic processes. Although we
were not able to identify the original cause of the observed chro-
mosome congression defect (reviewed in Auckland & McAinsh,
2015), it is possible that global metabolic alterations or the dereg-
ulation of a combination of factors involved in chromosome
migratory mechanisms affect the cell’s ability to properly align
chromosomes at the spindle equator and synchronously pull them
to the opposite poles. Accordingly, changes in transcriptional
programs might be the driving parameter for the developmental
defects observed in PWWP2A-depleted X. laevis and X. tropicalis
embryos. Our analyses revealed that PWWP2A’s function in
neural crest cell differentiation and/or migration during early
development is evolutionary conserved, as a rescue with human
PWWP2A RNA was overly successful. Indeed, PWWP2A’s rescu-
ing activity depends on the IC domain, suggesting that it exerts
its developmental function in the context of H2A.Z-containing
chromosomal sites.
We propose that PWWP2A modulates expression of many
H2A.Z-containing genes, and speculate that the combined deregula-
tion of metabolism and morphogenesis causes defects in mitotic
spindle pulling and sliding as well as neural crest stem cell migra-
tion and differentiation. The latter alterations are hallmarks of
human cranio-facial diseases, such as neurocristopathies (Zhang
et al, 2014) affecting facial features and include eye abnormalities,
as seen in DiGeorge, Treacher-Collins, or Waardenburg syndromes
(reviewed in Mayor & Theveneau, 2013). Although the genetic
causes of some of these diseases have been identified, for example,
the ATP-dependent chromatin remodeler CHD7 (Bajpai et al, 2010)
is mutated in CHARGE syndrome (Van Nostrand et al, 2014), the
genetic origin of many other neural crest-associated diseases is not
known. Future studies will elucidate whether mutations in
PWWP2A might contribute to the pathogenesis of human neuro-
cristopathies.
Materials and Methods
Cell culture and transfections
HeLa Kyoto (HeLaK) cells and metastatic melanoma Skmel-147
cells and were grown in DMEM medium (PPA), supplemented
with 10% FCS (Sigma-Aldrich) and 1% penicillin/streptomycin
(PAA) at 37°C and 5% CO2. DT40 cells were cultured and H2A.Z
expression suppressed as described (Kusakabe et al, 2016). HeLaK
and SKmel-147 cells expressing GFP-tagged histone variants are
culture as described in (Bonisch et al, 2012; Vardabasso et al,
2015). GFP-PWWP2A plasmids were transfected into HeLaK cells
using X-tremeGENE HP (Roche) according to the manufacturer’s
instructions and then selected in medium containing 400–600 lg/ml
G-148 sulfate liquid (PAA). Cell populations of 80–100% GFP-
positive stable cells were aspired after 3 weeks of selection and
employed for further experiments. Expression levels of GFP-
proteins were measured using a FACSCanto machine (BDI
Bioscience). Establishment and analysis of conditional H2A.Z DKO
cells expressing Flag-H2A.ZDC was done as described previously
(Kusakabe et al, 2016).
Antibodies
The following primary antibodies were used in this study: a-
PWWP2A (Novus (Acris), NBP2-13833), a-H2A.Z (Abcam, ab4174),
a-H2A (Abcam, ab13923), a-H3 (Abcam, ab1791), a-H3K4me3
(Diagenode, C15410003), a-H3K9me3 (Diagenode, C15410056), a-
H3K36me3 (Active Motif, 61101), a-H3S10ph (Active Motif, 39253
and 39636), a-GST (clone 6G9; gift from E. Kremmer, Helmholtz
Munich), a-GFP (Roche, 11814460001), a-CENP-E (Active Motif,
39620), a-ZNHIT1 (Sigma, HPA019043), a-alpha-Tubulin (Active
Motif, 39527), a-Flag (Sigma, F1804).
The following secondary antibodies were used: a-mouse HRP
(GE Healthcare, NA931), a-rabbit HRP (GE Healthcare, NA934), and
a-rat HRP (GE Healthcare, NA935), a-rabbit AlexaFluor 488
(Dianova, 711-545-152), a-mouse AlexaFluor 488 (Dianova, 715-
545-151), a-mouse AlexaFluor 555 (Life Technologies, A21424), a-
rabbit AlexaFluor 555 (Life Technologies, A31572), a-rabbit Alexa-
Fluor 594 (Dianova, 711-585-152), a-mouse AlexaFluor 594
(Dianova 715-585-151), a-rabbit IRDye 800CW (LI-COR Biosciences,
926-32211), or a-mouse IRDye 680RD (LI-COR Biosciences, 926-
68070).
Cloning
Total RNA from Skmel-147 cells was isolated using the RNeasy mini
kit (QIAGEN) and cDNA synthesized with the ProtoScript First
Strand cDNA Synthesis kit (NEB) according to the manufacturer’s
instructions and as described previously (Wiedemann et al, 2010).
A DNA fragment containing the PWW2A coding sequence and parts
of the 50 and 30 UTRs was amplified with a gene specific primer pair
(Fwd: 50-GGAGTTGGAGGAGGGAGAAG-30, Rev: 50-TTCCAATGGT
CTTGCCTACC-30) and Phusion DNA Polymerase (Biolabs). PCR
product was subcloned into the shuttle vector pT7blue3. The full-
length PWWP2A fragment was subsequently used in Gateway
cloning to create a N-terminally GFP-tagged PWWP2A fusion
protein construct (pIRESneo-eGFP-PWWP2A) for in vivo studies and
a GST-tagged PWWP2A fusion construct (pGEX6P1-PWWP2A) for
recombinant bacterial expression. In addition, several PWWP2A
truncation constructs for eukaryotic and bacterial expression were
created using Gateway and Gibson (Gibson et al, 2009) cloning
strategies. Flag-H2A and Flag-H2A.Z constructs are described in
Kusakabe et al (2016). Flag-H2A.ZDC was prepared by inserting a
chemically synthesized H2A.Z.1 cDNA (Eurofins Genomics) lacking
Gly120 to Val128 into the p3xFLAG-CMV10 plasmid (Sigma-
Aldrich).
Generation of S1 mononucleosomes
Mononucleosomes for IP experiments (qMS, ChIP-seq as well as
in vitro binding studies) were isolated as described previously
(Sansoni et al, 2014) and the S1 fraction used for subsequent
experiments.
Generation of mononucleosomes from DKO cells was performed
as described in (Kusakabe et al, 2016) with one modification: At the
last step of the preparation, the nucleosome pellet was solubilized
with a buffer containing 150 mM NaCl instead of 500 mM NaCl.
The mono-nucleosome fraction was checked by electrophoresis on
2% agarose gel.
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Label-free quantitative mass spectrometry (LFQ-MS) and
data analysis
Mononucleosome immunoprecipitations, LC-MS/MS analysis, and
MS Raw Data Analysis were basically carried out as previously
described (Vardabasso et al, 2015). For more details see the
Appendix Supplementary Methods.
nChIP-seq
Immunoprecipitations were carried out with S1 mononucleosomes
derived from HeLaK cells stably expressing GFP or GFP-tagged H2A,
H2A.Z.1, H2A.Z.2, or PWWP2A from 4 × 107 cells in 1.5 ml low-
binding tubes. For more details, see the Appendix Supplementary
Methods.
RNA-seq and data analysis
Total RNA from HeLaK cells subjected to PWWP2A siRNAs and
control siRNAs was isolated utilizing the RNeasy mini kit (Qiagen)
according to manufacturer’s instructions. The quality of the RNA
(amount and integrity) was assessed using the BioAnalyzer and a
RNA 6000 pico kit (Agilent). mRNA isolation, fragmentation, first-
and second-strand cDNA synthesis and end repair were carried out
using the NEBNext Ultra RNA library prep kit for Illumina (NEB)
following the manufacturer’s instructions. cDNA sequencing
libraries were established with the MicroPlex Library Preparation
Kit (Diagenode).
Next generation sequencing (50 bp, single end) was performed
by Dr. Stefan Krebs at the Laboratory of Functional Genome Analy-
sis (LAFUGA) in Munich (Gene Center).
Raw sequencing reads were aligned to the human genome
(GRCh38) using kallisto (v 0.42.4; Bray et al, 2016) with parameters
“-t 8 -b 100 –single -l 190 -s 10”. Differential expression was tested
using an R/sleuth model including the experimental batch as
random effect (preprint: Pimentel et al, 2016). Responders were
defined by a q-value cutoff < 5%. Gene Ontology group enrichment
for differentially expressed genes was defined using the “goana”
function in R/limma. GO groups were kept for visualization using
REVIGO (Supek et al, 2011), if group size was larger than 19 genes
and the P-value smaller than 5%.
Recombinant expression and purification of GST proteins and
in vitro binding studies
Expression and purification of GST proteins are described in detail
in the Appendix Supplementary Methods.
Fluorescence recovery after photobleaching and live cell imaging
Fluorescence recovery after photobleaching analyses were
performed essentially as described in Schneider et al (2013). For
more details, see the Appendix Supplementary Methods.
Electrophoretic mobility shift assay
Details on all electrophoretic mobility shift assays (EMSAs) can be
found in the Appendix Supplementary Methods.
RNAi, cell cycle and proliferation analysis
siRNAs were designed using siDESIGN Center (http://dharmacon.
gelifesciences.com/design-center/?redirect=true) and synthesized
(MWG-Biotech AG). siRNAs were prevalidated by BLAST searches
(NCBI) to confirm their targeting specificity to PWWP2A and to
reduce the chance of off-target effects. The following double-
stranded siRNAs were used: Luciferase, 50-CUUACGCUGAGUAC
UUCGA-30; ctrlII, 50-UAAGGCUAUGAAGAGAUACTT-30; PWWP
2A#1, 50-GGACAGAAGUCAAGUGUGAUUTT-30; PWWP2A#2, 50-G
CUAUUAAACUACGACCCAUUTT-30; cells were transfected with
siRNA using oligofectamine (Invitrogen) according to the manufac-
turer’s instructions. Two to three days after transfection, cells
were used for various assays that are described in detail in the
Appendix Supplementary Methods.
IF microscopy (confocal, chromosome spreads)
IF stainings were performed as previously described (Wiedemann
et al, 2010; Mulholland et al, 2015). Metaphase Spreads were
prepared as described previously (Jeppesen, 2000). For details, see
the Appendix Supplementary Methods.
Modeling of PWWP domain structure
A potential structure of the PWWP domain of PWWP2A was
modeled employing the web browser-based tool iTASSER (http://
zhanglab.ccmb.med.umich.edu/I-TASSER/; Roy et al, 2010) and
visualized with the freely available software Chimera (1.8.0).
Template was the already published structure of the PWWP2B
PWWP domain (Qin & Min, 2014), Protein Data Bank (PDB)
code 4LD6. The predicted PWWP2A structure was compared to
the published structure of the DNA-binding PWWP domain of
PSIP1 (Eidahl et al, 2013), PDB code 4FU6). The Electrostatic
Surface Potential (ESP) of PSIP1 and PWWP2A was calculated
utilizing the Coulombic Surface Coloring algorithm, which is
part of the Chimera (1.8.0) software package, using default
settings.
Xenopus experiments
Expression constructs and in vitro transcription
For rescue experiments, the human full-length pwwp2a sequence
(NM_001130864.1) was cloned into the pCS2 + expression vector
with a N-terminal GFP-tag. For testing morpholino targeting efficien-
cies, the cDNA region from 121 to +154 of X. laevis pwwp2a was
fused in frame to the luciferase ORF in a gateway-compatible
pCS2 + vector. Capped mRNA for microinjection was synthesized
as described (Steinbach et al, 1997).
Morpholino Oligonucleotides
The pwMO morpholino oligonucleotide against the translational
start site of pwwp2a mRNAs was purchased from GeneTools: 50-
GCCGCCATTTTATCTTTCGCTTCTC-30. This oligonucleotide is fully
complementary to the X. laevis pwwp2a mRNA (XeXenL6RM
v10002517 m, Xenbase) and has a single mismatch to the X. tropi-
calis (XM_002940175) homolog. The unrelated standard control
Morpholino (CoMO) served as control for specificity.
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Embryo handling
Xenopus laevis and Xenopus tropicalis eggs were collected, in vitro
fertilized, microinjected, and cultivated following standard proce-
dures. Embryos were staged according to Nieuwkoop and Faber
(Nieuwkoop & Faber, 1994). The morpholino oligonucleotides were
injected in one blastomere at the 2-cell stage for morphological and
molecular analyses. For CoMO and pwMO (20 ng/blastomere),
Alexa Dextrans (Invitrogen) Fluor-488 (green) or Alexa-594 (red)
were coinjected as lineage tracer. For rescue experiments, 250 pg of
in vitro transcribed human GFP-PWWP2A mRNAs (wild-type and
mutants) was co-injected with Morpholinos and Alexa-594 Dextran;
synthesis of the PWWP2A proteins was verified by GFP fluores-
cence.
RNA in situ hybridization and cartilage staining
Whole-mount RNA in situ hybridizations was performed as
described (Sive et al, 2000). Cartilage was stained with Alcian Blue
as described (Bellmeyer et al, 2003) and dissected from stained
embryos for better visualization. Embryos were photographed under
bright light with a Leica M205FA stereomicroscope.
Luciferase assay
The Morpholino oligo was injected into both blastomeres at the 2-
cell stage, followed by injection of Xl pwwp2a/luci mRNA at 4-cell
stage in all blastomeres. Luciferase chemiluminescence was
measured at mid-gastrula and normalized to CoMO conditions.
Ethics statements
Experiments on frogs were done in accordance with Deutsches Tier-
schutzgesetz; experimental use of Xenopus embryos has been
licensed by the Government of Oberbayern (project/AK ROB:
55.2.1.54-6.3-11).
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